Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma

Annals of Surgical Oncology

Volumn 17, Issue 5, 2010, Pages 1311-1323

  Rahadiani, Nur ^a   Ikeda, Jun Ichiro ^a   Makino, Tomoki ^a   Tian, Tian ^a   Qiu, Ying ^a,b   Mamat, Suhana ^a,c   Wang, Yi ^a   Doki, Yuichiro ^a   Aozasa, Katsuyuki ^a   Morii, Eiichi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b TONGJI UNIVERSITY   (China)

^c INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; PODOPLANIN; TOPOTECAN; TUMOR MARKER;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

AGED; AGED, 80 AND OVER; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; ESOPHAGEAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; GENE SILENCING; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TOPOTECAN; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77952090143     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0895-5     Document Type: Article

References (32)

1. GH Heppner 1984 Tumor heterogeneity Cancer Res 44 2259 2265 1:STN:280:DyaL2c3gsFemtw%3D%3D 6372991
2. AW Hemburger SE Salmon 1977 Primary bioassay of human tumor stem cells Cell Sci 197 461 463
3. WR Bruce H Van Der Gaag 1963 A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo Nature 199 79 80 10.1038/199079a0 1:STN:280:DyaF2c%2FgsFGnsg%3D%3D 14047954
4. T Reya SJ Morrison MF Clarke IL Weissman 2001 Stem cells, cancer, and cancer stem cells Nature 414 105 111 10.1038/35102167 1:CAS:528: DC%2BD3MXot1ahs7c%3D 11689955 (Pubitemid 33041634)
5. D Bonnet JE Dick 1997 Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat Med 3 730 737 10.1038/nm0797-730 1:CAS:528:DyaK2sXkt1GrtLY%3D 9212098 (Pubitemid 27298715)
6. J Lessard G Sauvageau 2003 Bmi-1 determined the proliferative capacity of normal and leukaemic stem cells Nature 423 255 260 10.1038/nature01572 1:CAS:528:DC%2BD3sXjs1yntbg%3D 12714970 (Pubitemid 40852690)
7. M Al-Hajj MS Wicha A Benito-Hernandez SJ Morrison MF Clarke 2003 Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci USA 100 3983 3988 10.1073/pnas.0530291100 1:CAS:528:DC%2BD3sXivFSqtbs%3D 12629218 (Pubitemid 36418143)
8. SK Singh ID Clarke M Terasaki, et al. 2003 Identification of a cancer stem cell in human brain tumors Cancer Res 63 5821 5828 1:CAS:528: DC%2BD3sXnvVSjtbc%3D 14522905 (Pubitemid 37187480)
9. AT Collins PA Berry C Hyde MJ Stower NJ Maitland 2005 Prospective identification of tumorigenic prostate cancer stem cells Cancer Res 65 10946 10951 10.1158/0008-5472.CAN-05-2018 1:CAS:528:DC%2BD2MXht1KjsrzP 16322242 (Pubitemid 41713363)
10. D Fang TK Nguyen K Leishear, et al. 2005 A tumorigenic subpopulation with stem cell properties in melanomas Cancer Res 65 9328 9337 10.1158/0008-5472. CAN-05-1343 1:CAS:528:DC%2BD2MXhtFWmu7zI 16230395 (Pubitemid 41508000)
11. L Ricci-Vitiani DG Lombardi E Pilozzi, et al. 2007 Identification and expansion of human colon-cancer-initiating cells Nature 2445 111 115 10.1038/nature05384 (Pubitemid 46067311)
12. C Li DG Heidt P Dalerba, et al. 2007 Identification of pancreatic cancer stem cells Cancer Res 67 1030 1037 10.1158/0008-5472.CAN-06-2030 1:CAS:528:DC%2BD2sXht1yns70%3D 17283135 (Pubitemid 46270758)
13. ME Prince R Sivanandan A Kaczorowski, et al. 2007 Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma Proc Natl Acad Sci USA 104 973 978 10.1073/pnas. 0610117104 1:CAS:528:DC%2BD2sXhtVSitLk%3D 17210912 (Pubitemid 46154721)
14. + cancer stem cells in human liver cancer Cancer Cell 13 153 156 10.1016/j.ccr.2008.01. 013 1:CAS:528:DC%2BD1cXitFWrs7c%3D 18242515 (Pubitemid 351163165)
15. S Takaishi T Okumura S Tu, et al. 2009 Identification of gastric stem cells using the cell surface marker CD44 Stem Cells 27 1006 1020 10.1002/stem.30 1:CAS:528:DC%2BD1MXnsF2rs70%3D 19415765
16. N Atsumi G Ishii M Kijima, et al. 2008 Podoplanin a novel marker of tumor-initiating cells in human squamous cell carcinoma A431 Biochem Biophys Res Commun 373 36 41 10.1016/j.bbrc.2008.05.163 1:CAS:528:DC%2BD1cXnvVOhtLc%3D 18539139
17. A Wicki G Christofori 2007 The potential role of podoplanin in tumor invasion Br J Cancer 96 1 5 10.1038/sj.bjc.6603518 1:CAS:528: DC%2BD2sXis1Kgtg%3D%3D 17179989 (Pubitemid 46094630)
18. P Yuan S Temam A El Naggar, et al. 2006 Overexpression of podoplanin in oral cancer and its association with poor clinical outcome Cancer 107 563 569 10.1002/cncr.22061 1:CAS:528:DC%2BD28Xot1aksLc%3D 16804930 (Pubitemid 44107217)
19. KL Dumoff C Chu X Xu, et al. 2005 Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix Mod Pathol 18 97 104 10.1038/modpathol.3800269 1:CAS:528:DC%2BD2MXivVan 15467716 (Pubitemid 40128101)
20. T Ito G Ishii K Nagai, et al. 2009 Low podoplanin expression of tumor cells predicts poor prognosis in pathological stage IB squamous cell carcinoma of the lung, tissue microarray analysis of 136 patients using 24 antibodies Lung Cancer 63 418 424 10.1016/j.lungcan.2008.06.008 18657337
21. AP Vizcaino V Moreno R Lambert DM Parkin 2002 Time trends incidence of both major histologic types of esophageal carcinomas in selected countries 1973-1995 Int J Cancer 99 860 868 10.1002/ijc.10427 1:CAS:528: DC%2BD38XksVajsLw%3D 12115489 (Pubitemid 34575705)
22. M Morita R Yoshida K Ikeda, et al. 2008 Advances in esophageal cancer surgery in Japan: An analysis of 1000 consecutive patients treated at a single institute Surgery 143 499 508 10.1016/j.surg.2007.12.007 18374047
23. WJ Slichenmyer DD Von Hoff 1990 New natural products in cancer chemotherapy J Clin Pharmacol 30 770 788 1:STN:280:DyaK3M7hs1Smtw%3D%3D 1980498 (Pubitemid 20334336)
24. MT Tomicic M Christmann B Kaina 2005 Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survival Cancer Res 65 8920 8926 10.1158/0008-5472.CAN-05-0266 1:CAS:528:DC%2BD2MXhtVKiu73K 16204064 (Pubitemid 41377382)
25. KL Meyer-Siegler KA Iczknowski L Leng R Bucala PL Vera 2006 Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells J Immunol 177 8730 8739 1:CAS:528:DC%2BD28Xht1Kitr3N 17142775 (Pubitemid 44893839)
26. T Oda T Tian M Inoue, et al. 2009 Tumorigenic role of orphan nuclear receptor NR0B1 in lung adenocarcinoma Am J Pathol 175 1235 1245 10.2353/ajpath.2009.090010 1:CAS:528:DC%2BD1MXhtF2isbrE 19644015
27. M Diehn RW Cho NA Lobo, et al. 2009 Association of reactive oxygen species levels and radioresistance in cancer stem cells Nature 458 780 783 10.1038/nature07733 1:CAS:528:DC%2BD1MXhsVCrtbc%3D 19194462
28. W Song H Li K Tao, et al. 2008 Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma Int J Clin Pract 62 1212 1218 10.1111/j.1742-1241.2008.01777.x 1:CAS:528:DC%2BC3cXktFGgu7c%3D 18479363 (Pubitemid 351977611)
29. MT Mueller PC Hermann J Witthauer, et al. 2009 Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer Gastroenterology 137 1102 1112 10.1053/j.gastro.2009.05.053 1:CAS:528: DC%2BD1MXhtF2is77E 19501590
30. -/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis Clin Cancer Res 11 1154 1159 1:CAS:528:DC%2BD2MXht1ynt7k%3D 15709183 (Pubitemid 40175765)
31. FG Scholl C Gamallo S Vilaró M Quintanilla 1999 Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes J Cell Sci 112 4601 4613 1:CAS:528:DC%2BD3cXntlGitQ%3D%3D 10574709 (Pubitemid 30034809)
32. A Wicki F Lehembre N Wick, et al. 2006 Tumor invasion in the absence of epithelial-mesenchymal transition: Podoplanin-mediated remodeling of the actin cytoskeleton Cancer Cell 9 261 272 10.1016/j.ccr.2006.03.010 1:CAS:528:DC%2BD28XjvFeiurw%3D 16616332